dr. A.H. Brouwers
Telephone:
E-mail:
a.h.brouwers umcg.nl
Research
1 - 50 out of 129Page size: 50
- 2019
- van Helden, E. J., Elias, S. G., Gerritse, S. L., van Es, S. C., Boon, E., Huisman, M. C., ... van Oordt, C. W. M. D. H. (2019). [Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-019-04555-6
- Verhoeff, S., van Es, S. C., Boon, E., van Helden, E., Angus, L., Elias, S. G., ... van Herpen, C. M. L. (2019). Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18] FDG-PET in patients with newly diagnosed metastatic renal cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging, 46(SUPPL 1), S67-S67.
- de Hosson, L. D., van der Loo-van der Schaaf, A. M., Boellaard, R., van Snick, J. H., de Vries, E. G. E., Brouwers, A. H., & Walenkamp, A. M. E. (2019). Interlesional Heterogeneity of Metastatic Neuroendocrine Tumors Based on 18F-DOPA PET/CT. Clinical Nuclear Medicine, 44(8), 612-619. https://doi.org/10.1097/RLU.0000000000002640
- Jauw, Y. W. S., Bensch, F., Brouwers, A. H., Hoekstra, O. S., Zijlstra, J. M., Pieplenbosch, S., ... Huisman, M. C. (2019). Interobserver reproducibility of tumor uptake quantification with Zr-89-immuno-PET: a multicenter analysis. European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1840-1849. https://doi.org/10.1007/s00259-019-04377-6
- Verhoeff, S. R., van Es, S. C., Boon, E., van Helden, E., Angus, L., Elias, S. G., ... van Herpen, C. M. L. (2019). Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging, 46(9), 1931-1939. https://doi.org/10.1007/s00259-019-04358-9
- Noltes, M. E., Kruijff, S., Noordzij, W., Telenga, E. D., Vállez García, D., Trofimiuk-Müldner, M., ... Brouwers, A. H. (2019). Optimization of parathyroid C-11-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism. EJNMMI Research, 9(1), [73]. https://doi.org/10.1186/s13550-019-0534-5
- den Toom, I. J., Boeve, K., van Weert, S., Bloemena, E., Brouwers, A. H., Hoekstra, O. S., ... de Bree, R. (2019). High rate of unexpected lymphatic drainage patterns and a high accuracy of the sentinel lymph node biopsy in oral cancer after previous neck treatment. Oral Oncology, 94, 68-72. https://doi.org/10.1016/j.oraloncology.2019.05.007
- Holvast, A., Kats-Ugurlu, G., Bodewes, F. A. J. A., de Kleine, R. H. J., Porte, R. J., Brouwers, A. H., & van der Doef, H. P. J. (2019). Reversal of secondary protein-losing enteropathy after surgical revision of a jejunal Roux-en-Y loop in a patient after liver transplantation. American Journal of Transplantation, 19(7), 2116-2121. https://doi.org/10.1111/ajt.15354
- Moek, K. L., Waaijer, S. J. H., Kok, I. C., Suurs, F. V., Brouwers, A. H., Menke-van der Houven van Oordt, C. W., ... de Vries, E. G. (2019). Zr-89-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake. Clinical Cancer Research, 25(12). https://doi.org/10.1158/1078-0432.CCR-18-2918
- Boeve, K., Den Toom, I. J., Van Weert, S., Bloemena, E., Brouwers, A. H., Hoekstra, O. S., ... De Bree, R. (2019). Unexpected drainage patterns and high accuracy of SLNB in OSCC after previous neck treatment. Radiotherapy and Oncology, 132(Suppl.1), 13-14. [OC-022]. https://doi.org/10.1016/S0167-8140(19)30188-4
- Dutch Pediat Thyroid Canc Study Co, Selvakumar, T., Nies, M., Hesselink, M. S. K., Brouwers, A. H., van der Horst-Schrivers, A. N. A., ... Links, T. P. (2019). Long-term effects of radioiodine treatment on salivary gland function in adult survivors of pediatric differentiated thyroid carcinoma. Journal of Nuclear Medicine, 60(2), 172-177. https://doi.org/10.2967/jnumed.118.212449
- Eisses, B., Angus, L., van der Vegt, B., Sieuwerts, A. M., Kraan, J., Martens, J. W., ... Schroder, C. P. (2019). Non-invasive estrogen receptor assessment by [F-18]-fluorestradiol(FES)-PET or circulating tumor cells predicts receptor status in patients with metastatic breast cancer. Cancer Research, 79(4). https://doi.org/10.1158/1538-7445.SABCS18-PD4-09
- Dekker, B. L., van der Horst-Schrivers, A. N. A., Sluiter, W. J., Brouwers, A. H., Lentjes, E. G. W. M., Heijboer, A. C., ... Links, T. P. (2019). Clinical Applicability of Low Levels of Thyroglobulin Autoantibodies as Cutoff Point for Thyroglobulin Autoantibody Positivity. Thyroid, 29(1), 71-78. https://doi.org/10.1089/thy.2018.0195
- 2018
- Bensch, F., van der Veen, E. L., Lub-de Hooge, M. N., Jorritsma-Smit, A., Boellaard, R., Kok, I. C., ... de Vries, E. G. E. (2018). Zr-89-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer. Nature Medicine, 24(12), 1852-1858. https://doi.org/10.1038/s41591-018-0255-8
- Bensch, F., Brouwers, A. H., Lub-de Hooge, M. N., de Jong, J. R., van der Vegt, B., Sleijfer, S., ... Schröder, C. P. (2018). 89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up. European Journal of Nuclear Medicine and Molecular Imaging, 45(13), 2300-2306. https://doi.org/10.1007/s00259-018-4099-8
- de Heer, E. C., Brouwers, A. H., Boellaard, R., Sluiter, W. J., Diercks, G. F. H., Hospers, G. A. P., ... Jalving, M. (2018). Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative F-18-FDG PET/CT analysis. EJNMMI Research, 8(1), [101]. https://doi.org/10.1186/s13550-018-0453-x
- Noltes, M. E., Kruijf, S., Noordzij, W., Telenga, E., Vállez García, D., Trofmiuk-Müldner, M., ... Brouwers, A. H. (2018). Optimization of 11C-choline positron emission tomography protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism. European Journal of Nuclear Medicine and Molecular Imaging, 45, 89. https://doi.org/10.1007/s00259-018-4148-3
- Verhoeff, S. R., Es, S., Boon, E., van Helden, E., Angus, L., Elias, S., ... van Herpen, C. M. L. (2018). Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC). Annals of Oncology, 29(Suppl.8), viii314-viii315. [888P]. https://doi.org/10.1093/annonc/mdy283.097
- Moek, K. L., Waaijer, S. J. H., Kok, I. C., Suurs, F. V., Brouwers, A., van Oordt, C. W. M. D. H., ... de Vries, E. G. E. (2018). Zirconium-89 (89Zr)-labeled bispecific T-cell engager (BiTE (R)) AMG 211 PET imaging to determine AMG 211 biodistribution in patients with gastrointestinal (GI) adenocarcinomas. Annals of Oncology, 29(Suppl.8).
- Berends, A. M. A., Kerstens, M. N., Bolt, J. W., Links, T. P., Korpershoek, E., de Krijger, R. R., ... van der Horst-Schrivers, A. N. A. (2018). False-positive findings on 6-[18F]fluor-L-3,4-dihydroxyphenylalanine PET (F-18-FDOPA-PET) performed for imaging of neuroendocrine tumors. European Journal of Endocrinology, 179(2), 125-133. https://doi.org/10.1530/EJE-18-0321
- Boeve, K., Schepman, K. P., Schuuring, E., Roodenburg, J. L. N., Halmos, G. B., van Dijk, B. A. C., ... Witjes, M. J. H. (2018). High sensitivity and negative predictive value of sentinel lymph node biopsy in a retrospective early stage oral cavity cancer cohort in the Northern Netherlands. Clinical Otolaryngology, 43(4), 1080-1087. https://doi.org/10.1111/coa.13107
- Stevenson, M. G., Been, L. B., Hoekstra, H. J., Suurmeijer, A. J. H., Boellaard, R., & Brouwers, A. H. (2018). Volume of interest delineation techniques for F-18-FDG PET-CT scans during neoadjuvant extremity soft tissue sarcoma treatment in adults: a feasibility study. EJNMMI Research, 8(1), [42]. https://doi.org/10.1186/s13550-018-0397-1
- Stevenson, M. G., Seinen, J. M., Pras, E., Brouwers, A. H., van Ginkel, R. J., van Leeuwen, B. L., ... Hoekstra, H. J. (2018). Hyperthermic isolated limb perfusion, preoperative radiotherapy, and surgery (PRS) a new limb saving treatment strategy for locally advanced sarcomas. Journal of Surgical Oncology, 117(7), 1447-1454. https://doi.org/10.1002/jso.25008
- Holvast, B., Bodewes, F. A. J. A., De Kleine, R. H. J., Porte, R. J., Brouwers, A. H., Kats-Ugurlu, G., & Van Der Doef, H. P. J. (2018). Roux loop revision for treatment of focal protein losing enteropathy in the Roux-Y loop after liver transplantation. Journal of Pediatric Gastroenterology and Nutrition, 66, 699-700.
- Nies, M., Dekker, B. L., Sulkers, E., Huizinga, G. A., Klein Hesselink, M., Maurice-Stam, H., ... Links, T. P. (2018). Psychosocial development in survivors of childhood differentiated thyroid carcinoma: a cross-sectional study. European Journal of Endocrinology, 178(3), 215-223. https://doi.org/10.1530/EJE-17-0741
- Bensch, F., Smeenk, M. M., van Es, S. C., de Jong, J. R., Schröder, C. P., Oosting, S. F., ... de Vries, E. G. E. (2018). Comparative biodistribution analysis across four different Zr-monoclonal antibody tracers-The first step towards an imaging warehouse. Theranostics, 8(16), 4295-4304. https://doi.org/10.7150/thno.26370
- Pfaehler, E., Burggraaff, C., Kramer, G., Zijlstra, J., Hoekstra, OS., Jalving, M., ... Boellaard, R. (2018). PET segmentation of bulky tumors: inter-observer variability of four segmentation approaches. European Journal of Nuclear Medicine and Molecular Imaging, 45, S44.
- 2017
- Hesselink, M. S. K., Bocca, G., Hummel, Y. M., Brouwers, A. H., Burgerhof, J. G. M., van Dam, E. W. C. M., ... Tissing, W. J. E. (2017). Diastolic Dysfunction is Common in Survivors of Pediatric Differentiated Thyroid Carcinoma. Thyroid, 27(12), 1481-1489. https://doi.org/10.1089/thy.2017.0383
- Noltes, M. E., Coester, A. M., van der Horst-Schrivers, A. N. A., Dorgelo, B., Jansen, L., Noordzij, W., ... Kruijff, S. (2017). Localization of parathyroid adenomas using 11C-methionine pet after prior inconclusive imaging. Langenbecks Archives of Surgery, 402(7), 1109-1117. https://doi.org/10.1007/s00423-017-1549-x
- Bensch, F., Lamberts, L. E., Smeenk, M. M., Jorritsma-Smit, A., Lub-de Hooge, M. N., Terwisscha van Scheltinga, A. G. T., ... de Vries, E. G. (2017). Zr-89-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors. Clinical Cancer Research, 23(20), 6128-6137. https://doi.org/10.1158/1078-0432.CCR-17-0311
- Schreuder, R. S. B. H., Brouwers, A. H., Elsinga, P. H., Slart, R. H. J. A., Walenkamp, A. M. E., Glaudemans, A. W. J. M., & Luurtsema, G. (2017). Quantification of 6-[F-18]fluoro-L-3,4-dihydroxyphenyl alanine Uptake in Neuroendocrine Tumour Lesions: The Effect of Specific Activity. European Journal of Nuclear Medicine and Molecular Imaging, 44, S691-S692.
- Moek, K. L., Giesen, D., Kok, I. C., de Groot, D. J. A., Jalving, M., Fehrmann, R. S. N., ... de Vries, E. G. E. (2017). Theranostics Using Antibodies and Antibody-Related Therapeutics. Journal of Nuclear Medicine, 58(Suppl 2), 83S-90S. https://doi.org/10.2967/jnumed.116.186940
- Klein Hesselink, E. N., Horst-Schrivers, van der, A., van der Horst, I. C. C., Bakker, S. J. L., Muller Kobold, A. C., Brouwers, A. H., ... Lefrandt, J. D. (2017). NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk. Clinical biochemistry, 50(12), 696-702. https://doi.org/10.1016/j.clinbiochem.2017.02.020
- van Es, S. C., Brouwers, A. H., Mahesh, S. V. K., Leliveld-Kors, A. M., de Jong, I. J., Lub-de Hooge, M. N., ... Oosting, S. F. (2017). 89Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma. Journal of Nuclear Medicine, 58(6), 905-910. https://doi.org/10.2967/jnumed.116.183475
- Nies, M., Klein Hesselink, M. S., Huizinga, G. A., Sulkers, E., Brouwers, A. H., Burgerhof, J. G. M., ... Bocca, G. (2017). Long-Term Quality of Life in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma. Journal of Clinical Endocrinology and Metabolism, 102(4), 1218-1226. https://doi.org/10.1210/jc.2016-2246
- Groen, A. H., Klein Hesselink, M., Plukker, J., Sluiter, W. J., Horst-Schrivers, van der, A., Brouwers, A. H., ... Links, T. P. (2017). Additional value of a high sensitive thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinoma. Clinical Endocrinology, 86(3), 419-424. https://doi.org/10.1111/cen.13180
- Boeve, K., Schepman, K-P., van der Vegt, B., Schuuring, E., Roodenburg, J. L., Brouwers, A. H., & Witjes, M. J. (2017). Lymphatic drainage patterns of oral maxillary tumors: Approachable locations of sentinel lymph nodes mainly at the cervical neck level. Journal of the Sciences and Specialties of the Head and Neck, 39(3), 486-491. https://doi.org/10.1002/hed.24628
- Schroder, C. P., Bensch, F., Brouwers, A. H., Lub-de Hooge, M. N., de Jong, J. R., van der Vegt, B., ... de Vries, E. G. (2017). Clinical value of Zr-89-trastuzumab PET in HER2-positive breast cancer patients with a clinical dilemma. Cancer Research, 77(4). https://doi.org/10.1158/1538-7445.SABCS16-P5-03-06
- van der Plas, W. Y., Noltes, M. E., Schaeffers, A. W. M. A., Brouwers, A. H., van der Horst-Schrivers, A. N. A., & Kruijff, S. (2017). De diagnostiek en behandeling van primaire hyperparathyreoïdie. Nederlands Tijdschrift voor Geneeskunde, 161(0), [D1870].
- 2016
- Klein Hesselink, E., Brouwers, A. H., Jong, de, J. R., van der Horst-Schrivers, A. N. A., Coppes, R. P., Lefrandt, J. D., ... Links, T. P. (2016). Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study. Journal of Nuclear Medicine, 57(11), 1685-1691. https://doi.org/10.2967/jnumed.115.169888
- Ebben, C. W. J., & Brouwers, A. (2016). Richtlijn Melanoom: Modulaire revisie 2016. Nederlands Tijdschrift voor Oncologie, 13(6), 218-220.
- Oosting, S. F., van Asselt, S. J., Brouwers, A. H., Bongaerts, A. H. H., Steinberg, J. D. J., de Jong, J., ... Links, T. P. (2016). Zr-89-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease. Journal of Nuclear Medicine, 57(8), 1244-1250. https://doi.org/10.2967/jnumed.115.167643
- Kist, J. W., de Keizer, B., van der Vlies, M., Brouwers, A. H., Huysmans, D. A., van der Zant, F. M., ... THYROPET Study Grp (2016). I-124 PET/CT to Predict the Outcome of Blind I-131 Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET). Journal of Nuclear Medicine, 57(5), 701-707. https://doi.org/10.2967/jnumed.115.168138
- Klein Hesselink, M. S., Nies, M., Bocca, G., Brouwers, A. H., Burgerhof, J. G. M., van Dam, E. W. C. M., ... Links, T. P. (2016). Pediatric Differentiated Thyroid Carcinoma in The Netherlands: A Nationwide Follow-Up Study. Journal of Clinical Endocrinology and Metabolism, 101(5), 2031-2039. https://doi.org/10.1210/jc.2015-3290
- van Asselt, S. J., Brouwers, A. H., van Dullemen, H. M., van der Jagt, E. J., Bongaerts, A. H., Koopmans, K. P., ... Links, T. P. (2016). Potential value of EUS in pancreatic surveillance of VHL patients. European Journal of Endocrinology, 174(5), 611-620. https://doi.org/10.1530/EJE-15-1012
- Niebling, M. G., Pleijhuis, R. G., Bastiaannet, E., Brouwers, A. H., van Dam, G. M., & Hoekstra, H. (2016). A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping. European Journal of Surgical Oncology, 42(4), 466-473. https://doi.org/10.1016/j.ejso.2015.12.007
ID: 324562